Cingulate reports Q1 results
Source: SeekingAlpha
2025-05-09 04:21:44 ET
- Cingulate press release ( NASDAQ: CING ): Q1 net loss was $3.8 million for the three months ended March 31, 2025, compared to $3.0 million for the three months ended March 31, 2024.
- As of March 31, 2025, Cingulate had approximately $9.5 million in cash and cash equivalents, a $2.7 million decrease from December 31, 2024 and cash runway into the fourth quarter of 2025, beyond its targeted submission of the NDA for CTx-1301.
Read the full article on Seeking Alpha
For further details see:
Cingulate reports Q1 results
Cingulate Inc.
NASDAQ: CING
CING Trading
7.28% G/L:
$4.865 Last:
425,304 Volume:
$4.78 Open:
CING Latest News
CING Stock Data
$50,783,671
7,145,456
0.54%
16
N/A
Biotechnology & Life Sciences
Healthcare
US
Kansas City
